Trial intelligence / Profile preview

Memantine in Moderate to Severe Alzheimer's Disease

NCT00800709Phase 4Completed

Sponsor
Shanghai Mental Health Center
Start
Jul 2008
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Shanghai Mental Health Center. Started Jul 2008; status: completed.

02

Drugs

memantine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT00800709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00800709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call